Transparency Market Research is publishing a report titled, “Diabetic Lancing Device Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025, ” provides key insights on the diabetic lancing device market. The new report anticipates that the rise in prevalence of diabetic population, increase in awareness about blood glucose monitoring devices, and increased awareness about safety measures in order to avoid infectious diseases drive the diabetic lancing device market during the forecast period i. e, 2017-2025.
The report has segmented the global diabetic lancing devices market based on type, penetration depth, gauge, end user, and region. In terms of type, the diabetic lancing devices market is divided into safety lancets and standard lancets.
The safety lancets segment is further split into pressure-activated safety lancets, push-button safety lancets, and side-button safety lancets. Based on gauge, the diabetic lancing devices market is classified into 17/18g, 21g, 23g, and others. In accordance with penetration depth, the diabetic lancing devices market is bifurcated into 0.8 mm to 1.0 mm, 1.1 mm to 1.5 mm, 1.6 mm to 2.0 mm, and others. On the basis of end user, the diabetic lancing devices market is segregated into hospitals & clinics, home care & home diagnostics, diagnostic centers & medical institutions, research & academic laboratories, and others.
In terms of geographical perspective, the diabetic lancing devices market is categorized into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. Each region is further segmented into specific countries such as the U. S. , Canada, Germany, the U. K. , Brazil, China, India, Japan, and GCC countries.
Among these, the report anticipates that Europe will hold a dominant share of the global diabetic lancing device market owing to change in lifestyle and increase in R&D activities for the development of new drugs.
According to the International Diabetes Federation (IDF), in 2015, approximately 59.8 million people had diabetes in Europe. HTL Strefa and Sarstedt are two European companies that have marked their presence on a global level as major manufacturers of lancets and safety lancets in the world. North America is projected to be a highly attractive region of the market over the forecast period owing to rise in prevalence in diabetes in the region.
Prominent players operating in the market are profiled in this report to give a better competitive analysis and these include Terumo Corporation, B. Braun Melsungen AG, Becton Dickinson, F. Hoffmann-La Roche AG, Sanofi, Bayer AG, Eli Lilly and Company, Novo Nordisk A/S Owen Mumford Ltd, Medtronic, Ypsomed Holding AG, Sarstedt AG & Co, Greiner Bio One, Abbott Laboratories, HTL-STREFA S. A, and other prominent players. In order to gain competitive advantage in the industry, major players are actively involved in various growth strategies. Collaborations, agreements, partnerships, and new product launches are some of the important strategies adopted by market players, says the report.
Request a free brochure report here - http://bit.ly/2BU9jvm
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. We are leaders in analytics, research, and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a preeminent provider of cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who hold a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence. TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453